In recent years, there has been an increase in the diagnosis of infertility. In industrialized countries, approximately 15% of couples experience this problem today, with a negative impact on quality of life. For this reason, assisted reproductive technologies and other treatments, finalized to overcome infertility, have become very common in clinical practice. For a long time, different ovulation-inducing drugs have been used for ovarian follicle stimulation, either as independent therapies or treatments used during in vitro fertilization cycles. Despite this long-term use, the medical care for infertility gave rise to a lively debate about the potential risk of developing breast cancer that has never been settled. Many studies have been conducted to address this question; but their results have been, and still are, contradictory. The aim of this review is to determine the potential link between the use of fertility drugs and the risk of developing breast cancer in women treated for infertility.

Breast cancer risk after exposure to fertility drugs / LO RUSSO, Giuseppe; Spinelli, GIAN PAOLO; Tomao, Silverio; Belardino, Rossi; Frati, Luigi; BENEDETTI PANICI, Pierluigi; Patrizia, Vici; CODACCI PISANELLI, Giovanni; Tomao, Federica. - In: EXPERT REVIEW OF ANTICANCER THERAPY. - ISSN 1473-7140. - STAMPA. - 13:2(2013), pp. 149-157. [10.1586/era.12.181]

Breast cancer risk after exposure to fertility drugs

Giuseppe Lo Russo;SPINELLI, GIAN PAOLO;TOMAO, SILVERIO;FRATI, Luigi;BENEDETTI PANICI, PIERLUIGI;CODACCI PISANELLI, Giovanni;TOMAO, FEDERICA
2013

Abstract

In recent years, there has been an increase in the diagnosis of infertility. In industrialized countries, approximately 15% of couples experience this problem today, with a negative impact on quality of life. For this reason, assisted reproductive technologies and other treatments, finalized to overcome infertility, have become very common in clinical practice. For a long time, different ovulation-inducing drugs have been used for ovarian follicle stimulation, either as independent therapies or treatments used during in vitro fertilization cycles. Despite this long-term use, the medical care for infertility gave rise to a lively debate about the potential risk of developing breast cancer that has never been settled. Many studies have been conducted to address this question; but their results have been, and still are, contradictory. The aim of this review is to determine the potential link between the use of fertility drugs and the risk of developing breast cancer in women treated for infertility.
2013
breast cancer; ovarian stimulation; in vitro fertilization; breast cancer risk; fertility; clomiphene citrate; fertility drugs
01 Pubblicazione su rivista::01a Articolo in rivista
Breast cancer risk after exposure to fertility drugs / LO RUSSO, Giuseppe; Spinelli, GIAN PAOLO; Tomao, Silverio; Belardino, Rossi; Frati, Luigi; BENEDETTI PANICI, Pierluigi; Patrizia, Vici; CODACCI PISANELLI, Giovanni; Tomao, Federica. - In: EXPERT REVIEW OF ANTICANCER THERAPY. - ISSN 1473-7140. - STAMPA. - 13:2(2013), pp. 149-157. [10.1586/era.12.181]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/524813
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact